Page 7 - Point Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Point Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Point Pharma Today - Breaking & Trending Today

10 Stocks to Invest in Under $20 According to Michael Castor's Sio Capital

Published: May 11, 2022

In this piece, we will take a look at the ten stocks to invest in under $20 according to Sio Capital.

Source: insidermonkey.com

Oyster Point Pharma (NASDAQ:OYST) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Published: May 7, 2022

Oyster Point Pharma (NASDAQ:OYST – Get Rating) posted its quarterly earnings data on Thursday. The company reported ($1.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.75) by ($0.05), Fidelity Earnings reports. During the same period last year, the business posted ($0.73) earnings per share. NASDAQ:OYST traded down $0.46 during mid-day […]

Source: etfdailynews.com

Oyster Point Pharma to Present New Analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022

Published: April 27, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com

Oyster Point Pharma (NASDAQ:OYST) Upgraded to "Hold" by Zacks Investment Research

Published: April 11, 2022

Zacks Investment Research upgraded shares of Oyster Point Pharma (NASDAQ:OYST – Get Rating) from a sell rating to a hold rating in a report published on Thursday, Zacks.com reports. According to Zacks, “Oyster Point Pharma Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of pharmaceutical therapies to treat […]

Source: etfdailynews.com